Indoco Remedies Ltd - 532612 - Board Meeting Intimation for Unaudited Financial Results For First Qtr Ended 30.06.2019
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Unaudited financial results for the First quarter ended 30.06.2019 INDOCO REMEDIES LTD. - 532612 - Disclosure Under Reg.29(2) Of SEBI Regulations, 2011
Purchase of shares by KMP INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA concludes inspection of Indoco''s Sterile facility (Plant-II) Indoco Remedies Ltd - 532612 - Regulation 23(9)
Disclosure of Related Party Transactions on a consolidated basis and balances for the half year ended 31.03.2019 INDOCO REMEDIES LTD. - 532612 - Board recommends Dividend
Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, has recommended dividend of Rs. 0.30/- per share (15%) on face value of Rs. 2/- each for the financial year 2018-19, subject to the Members approval at the AGM. INDOCO REMEDIES LTD. - 532612 - Result For The Quarter & Year Ended 31.03.2019
Result for the FY 31.03.2019 Indoco Remedies Ltd - 532612 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm A. Y. SATHE & CO. 4 Name of the Certifying Individual AJIT SATHE 5Membership TypeFCS 6 Membership Number 2899 7 CP No. 738 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Institutional Investor Meet